Larvol Delta - TRPC6-inhibitor-BI-764198-to-reduce-risk-and-severity-of-ARDS-due-to-COVID19-a-phase-II-randomised-controlled-trial

BI 764198 - Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/37024277

Apr 7, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next